Does BORTEZOMIB Cause Hepatitis b reactivation? 85 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 85 reports of Hepatitis b reactivation have been filed in association with BORTEZOMIB (bortezomib). This represents 0.2% of all adverse event reports for BORTEZOMIB.
85
Reports of Hepatitis b reactivation with BORTEZOMIB
0.2%
of all BORTEZOMIB reports
15
Deaths
5
Hospitalizations
How Dangerous Is Hepatitis b reactivation From BORTEZOMIB?
Of the 85 reports, 15 (17.6%) resulted in death, 5 (5.9%) required hospitalization.
Is Hepatitis b reactivation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BORTEZOMIB. However, 85 reports have been filed with the FAERS database.
What Other Side Effects Does BORTEZOMIB Cause?
Plasma cell myeloma (6,683)
Off label use (4,754)
Neuropathy peripheral (4,067)
Drug ineffective (2,730)
Diarrhoea (2,244)
Thrombocytopenia (2,082)
Death (2,025)
Pneumonia (2,020)
Fatigue (1,757)
Neutropenia (1,530)
What Other Drugs Cause Hepatitis b reactivation?
RITUXIMAB (914)
CYCLOPHOSPHAMIDE (801)
DOXORUBICIN (684)
VINCRISTINE (641)
PREDNISONE (583)
PREDNISOLONE (465)
LAMIVUDINE (308)
METHOTREXATE (305)
DEXAMETHASONE (293)
ETOPOSIDE (213)
Which BORTEZOMIB Alternatives Have Lower Hepatitis b reactivation Risk?
BORTEZOMIB vs BOSENTAN
BORTEZOMIB vs BOSENTAN\BOSENTAN
BORTEZOMIB vs BOSULIF
BORTEZOMIB vs BOSUTINIB
BORTEZOMIB vs BOTOX